2026. Dapagliflozin and Urinary Tract Infection Risk in Type 2 Diabetes: A Comprehensive Critical Review of Mechanistic, Randomized, and Real-World Evidence. Tropical Journal of Pharmaceutical and Life Sciences. 13, 5 (Oct. 2026), 53–68. DOI:https://doi.org/10.61280/9h681f91.